Egis Pharmaceuticals's operating cash flow reached HUF 26,342 mil in 2012, down 0.697% when compared to the previous year. Historically, the firm’s operating cash flow reached an all time high of HUF 26,527 mil in 2011 and an all time low of HUF 6,037 mil in 2003.
Egis Pharmaceuticals's total investments reached HUF 14,896 mil and accounted for 11.5% of sales in 2012. This is compared to 12.1% seen on average in the last five years.
Since cash from financing amounted to HUF -1,074 mil, net cash the company generated in 2012 reached HUF 45,929 mil.